Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-16 | MBX Biosciences, Inc. | Mathers Edward T
(Director) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | BASKETT FOREST
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Behbahani Ali
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Chang Carmen
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Florence Anthony ...
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Makhzoumi Mohamad
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Walker Paul Edward
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Yang Rick
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | SANDELL SCOTT D
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | OrbiMed Genesis G...
(Director) |
P | Common Stock | A | 750000 | $16.00 - $16.00 | $12,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | NEA 17 GP, LLC
(AtLeastTenPercentOwner) |
P | Common Stock | A | 500000 | $16.00 - $16.00 | $8,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Topper James N
(AtLeastTenPercentOwner) |
P | Common Stock | A | 625000 | $16.00 - $16.00 | $10,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Heron Patrick J
(Director) |
P | Common Stock | A | 625000 | $16.00 - $16.00 | $10,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | Aynechi Tiba
(Director) |
P | Common Stock | A | 750000 | $16.00 - $16.00 | $12,000,000 |
| 2024-09-16 | MBX Biosciences, Inc. | GORDON CARL L
(Director) |
P | Common Stock | A | 750000 | $16.00 - $16.00 | $12,000,000 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |